Recent News

• 11.12.2025 - DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
• 11.10.2025 - DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
• 11.06.2025 - DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025
• 09.29.2025 - DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
• 09.05.2025 - DiaMedica Therapeutics to Participate in Upcoming Investor Conferences
• 09.02.2025 - DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference
• 08.12.2025 - DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

Recent Filings

• 11.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.03.2025 - 3 Initial statement of beneficial ownership of securities
• 11.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 09.04.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.27.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.22.2025 - 424B2 Prospectus [Rule 424(b)(2)]
• 08.22.2025 - EFFECT Notice of Effectiveness
• 08.20.2025 - CORRESP Correspondence